Racial disparities in mortality are increasing. This article explores how the production of DNA-edited ethnically diverse ...

People with diabetes have a higher risk of developing Alzheimer's disease (AD) raising a possible link between the cells that ...

The company says preclinical trials demonstrate its signature molecule can help prevent cell damage that can lead to ...

Drugs targeting amyloid plaques have failed to show efficacy in clinical trials. A new approach is needed to tackle AD ...

A WOMAN who was jailed for stealing £20,000 from an old man with Alzheimer’s has revealed just what it was like in prison.

Light “turns certain biological signals on, which has downstream effects for the skin,” said Amit Om, a dermatologist in ...

Announced that topline data from the monotherapy Phase 3 VERITAC-2 trial isanticipated in 1Q25 –– Presented Phase 1b data from the TACTIVE-U ...

CU is participating in the nationwide “Guiding an Improved Dementia Experience” Model, a new health care payment and service delivery model that includes family caregiver support.

Financial writer recommends Voyager Therapeutics, Inc. for high-risk investors due to promising preclinical Alzheimer's ...

"Alzheimer's is a progressive neurodegenerative ... affecting myelin—an insulating layer that lines the outside of our nerve cells—production and subsequently disrupting neural communication.

Six new drugs, including a treatment for patients with advanced breast cancer, have been approved for use by the NHS in ...

Telomir announced results from its recent preclinical studies conducted in human cell lines. These studies demonstrated the ability of ...